Mounjaro (active ingredient: tirzepatide) subcutaneous injection Initial FDA Approval: 2022 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting
Lund, P
Weightloss with Semaglutide You are not alone if youre struggling to lose those extra pounds
However, adipose tissue inflammation and fibrosis persisted despite weight loss, as evidenced by sustained immune cell infiltration, collagen deposition, and activation of Yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ) signaling
The interaction between GLP-1, IELs and gut microbiota highlights its vital role in preserving the integrity of the intestinal mucosal barrier and the gut immunity homeostasis
At Gard Wellness Solutions, were here to help you find the best treatment for your weight-loss goals